Clene (CLNN) grants CFO 15,000 stock options at $5.53 strike

Rhea-AI Filing Summary

Clene Inc. reported that Chief Financial Officer Morgan R. Brown received a grant of stock options covering 15,000 shares of common stock. The options have an exercise price of $5.53 per share and expire on June 10, 2036. They vest 25% on June 11, 2027, with the remaining shares vesting in 36 equal monthly installments beginning July 11, 2027. This is a compensation-related award rather than an open‑market share purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider BROWN MORGAN R

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	stock option	15,000	$0.00	--

Holdings After Transaction: stock option — 15,000 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Options granted: 15,000 options Exercise price: $5.53 per share Post-transaction derivative holdings: 15,000 options +3 more

6 metrics

Options granted 15,000 options Stock option grant to CFO Morgan R. Brown

Exercise price $5.53 per share Strike price for 15,000 stock options

Post-transaction derivative holdings 15,000 options Total options held after this grant

Initial vesting date June 11, 2027 25% of options vest on this date

Monthly vesting installments 36 installments Remaining 75% vest monthly starting July 11, 2027

Option expiration June 10, 2036 Expiration date of granted options

Key Terms

stock option, exercise price, vesting, Clene Inc Amended 2020 Stock Plan

4 terms

stock option financial

"This option was granted on June 11, 2026 as an option for 15,000 shares of Common Stock"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

exercise price financial

"at an exercise price of $5.53 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting financial

"The options vest with respect to the first 25% of such shares on June 11, 2027"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Clene Inc Amended 2020 Stock Plan financial

"under the Clene Inc Amended 2020 Stock Plan at an exercise price of $5.53 per share"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BROWN MORGAN R

(Last) (First) (Middle)

6550 SOUTH MILLROCK DRIVE

SUITE G50

(Street)

SALT LAKE CITY UTAH 84121

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Clene Inc. [ CLNN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
stock option	$5.53	06/11/2026		A		15,000		(1)	06/10/2036	common stock	15,000	$0	15,000	D

Explanation of Responses:

1. This option was granted on June 11, 2026 as an option for 15,000 shares of Common Stock under the Clene Inc Amended 2020 Stock Plan at an exercise price of $5.53 per share. The options vest with respect to the first 25% of such shares on June 11, 2027 and then in 36 equal installments of the balance of the shares of Common Stock on the 11th day of each month beginning July 11, 2027 until such share are fully vested.

	/s/ Jerome T. Miraglia POA	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Clene (CLNN) report for CFO Morgan R. Brown?

Clene reported a compensation-related award to its CFO, Morgan R. Brown. He received a grant of stock options for 15,000 shares of common stock, rather than buying or selling shares in the open market.

How many Clene (CLNN) stock options were granted to the CFO and at what price?

The CFO received 15,000 stock options with an exercise price of $5.53 per share. This means he can buy up to 15,000 shares at $5.53, subject to the vesting schedule described in the award.

When do Morgan R. Brown’s Clene (CLNN) stock options vest?

The options vest 25% on June 11, 2027. The remaining 75% then vest in 36 equal monthly installments starting on July 11, 2027, gradually becoming exercisable over three additional years.

What is the expiration date of the Clene (CLNN) stock options granted to the CFO?

The stock options expire on June 10, 2036. After that date, any unexercised options will lapse, so the CFO must exercise vested options before this expiration if he wishes to purchase shares.

Is the Clene (CLNN) CFO’s Form 4 transaction an open-market purchase or sale?

The transaction is not an open-market trade. It is a grant of stock options under the Clene Inc. Amended 2020 Stock Plan, representing equity compensation rather than a discretionary market buy or sell.